Femoral vascular access for large-volume collection of peripheral blood progenitor cells

Sherry Shariatmadar, Thomas A. Noto

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Central venous catheters are used frequently in large-volume leukapheresis to provide high flow rates for peripheral blood progenitor cell (PBPC) collection. In a retrospective study, we evaluated the safety and efficacy of short-term use of large-bore femoral venous catheters for the collection of PBPCs in 63 patients with hematologic and solid organ malignancies. All catheters were placed in an outpatient setting on the day of apheresis and remained in site if subsequent collections became necessary. A total of 101 procedures were performed. Thirty-five patients (56%) reached target levels after 1 collection. Twenty-four patients (38%) had 2 consecutive day collections while 4 patients (6%) required more than 2 collections. In this latter group, 2 patients did not have consecutive day collections. One had 2 consecutive day collections followed by a third collection 48 hours later. In the other, leukapheresis was performed for 2 consecutive days and then resumed 3 days later with 2 subsequent collections. The longest duration the catheter remained in site was 6 days. Catheter care was provided by the apheresis staff. All patients who had more than 1 collection were given instructions on how to care for their catheters at home. Only 1 patient had oozing at the catheter site during the collection. Thrombosis, mechanical, and infectious complications were not encountered. The short-term use of femoral venous catheters appears safe and effective for the collection of PBPCs.

Original languageEnglish
Pages (from-to)99-102
Number of pages4
JournalJournal of Clinical Apheresis
Volume13
Issue number3
DOIs
StatePublished - Nov 17 1998

Fingerprint

Thigh
Blood Vessels
Blood Cells
Stem Cells
Catheters
Leukapheresis
Blood Component Removal
Central Venous Catheters
Thrombosis
Outpatients
Retrospective Studies
Safety
Neoplasms

Keywords

  • Catheter associated complications
  • PBPC collection
  • Vascular access

ASJC Scopus subject areas

  • Hematology

Cite this

Femoral vascular access for large-volume collection of peripheral blood progenitor cells. / Shariatmadar, Sherry; Noto, Thomas A.

In: Journal of Clinical Apheresis, Vol. 13, No. 3, 17.11.1998, p. 99-102.

Research output: Contribution to journalArticle

Shariatmadar, Sherry ; Noto, Thomas A. / Femoral vascular access for large-volume collection of peripheral blood progenitor cells. In: Journal of Clinical Apheresis. 1998 ; Vol. 13, No. 3. pp. 99-102.
@article{930a80bd27204f9bb76dc4f567d3a4a4,
title = "Femoral vascular access for large-volume collection of peripheral blood progenitor cells",
abstract = "Central venous catheters are used frequently in large-volume leukapheresis to provide high flow rates for peripheral blood progenitor cell (PBPC) collection. In a retrospective study, we evaluated the safety and efficacy of short-term use of large-bore femoral venous catheters for the collection of PBPCs in 63 patients with hematologic and solid organ malignancies. All catheters were placed in an outpatient setting on the day of apheresis and remained in site if subsequent collections became necessary. A total of 101 procedures were performed. Thirty-five patients (56{\%}) reached target levels after 1 collection. Twenty-four patients (38{\%}) had 2 consecutive day collections while 4 patients (6{\%}) required more than 2 collections. In this latter group, 2 patients did not have consecutive day collections. One had 2 consecutive day collections followed by a third collection 48 hours later. In the other, leukapheresis was performed for 2 consecutive days and then resumed 3 days later with 2 subsequent collections. The longest duration the catheter remained in site was 6 days. Catheter care was provided by the apheresis staff. All patients who had more than 1 collection were given instructions on how to care for their catheters at home. Only 1 patient had oozing at the catheter site during the collection. Thrombosis, mechanical, and infectious complications were not encountered. The short-term use of femoral venous catheters appears safe and effective for the collection of PBPCs.",
keywords = "Catheter associated complications, PBPC collection, Vascular access",
author = "Sherry Shariatmadar and Noto, {Thomas A.}",
year = "1998",
month = "11",
day = "17",
doi = "10.1002/(SICI)1098-1101(1998)13:3<99::AID-JCA1>3.0.CO;2-#",
language = "English",
volume = "13",
pages = "99--102",
journal = "Journal of Clinical Apheresis",
issn = "0733-2459",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Femoral vascular access for large-volume collection of peripheral blood progenitor cells

AU - Shariatmadar, Sherry

AU - Noto, Thomas A.

PY - 1998/11/17

Y1 - 1998/11/17

N2 - Central venous catheters are used frequently in large-volume leukapheresis to provide high flow rates for peripheral blood progenitor cell (PBPC) collection. In a retrospective study, we evaluated the safety and efficacy of short-term use of large-bore femoral venous catheters for the collection of PBPCs in 63 patients with hematologic and solid organ malignancies. All catheters were placed in an outpatient setting on the day of apheresis and remained in site if subsequent collections became necessary. A total of 101 procedures were performed. Thirty-five patients (56%) reached target levels after 1 collection. Twenty-four patients (38%) had 2 consecutive day collections while 4 patients (6%) required more than 2 collections. In this latter group, 2 patients did not have consecutive day collections. One had 2 consecutive day collections followed by a third collection 48 hours later. In the other, leukapheresis was performed for 2 consecutive days and then resumed 3 days later with 2 subsequent collections. The longest duration the catheter remained in site was 6 days. Catheter care was provided by the apheresis staff. All patients who had more than 1 collection were given instructions on how to care for their catheters at home. Only 1 patient had oozing at the catheter site during the collection. Thrombosis, mechanical, and infectious complications were not encountered. The short-term use of femoral venous catheters appears safe and effective for the collection of PBPCs.

AB - Central venous catheters are used frequently in large-volume leukapheresis to provide high flow rates for peripheral blood progenitor cell (PBPC) collection. In a retrospective study, we evaluated the safety and efficacy of short-term use of large-bore femoral venous catheters for the collection of PBPCs in 63 patients with hematologic and solid organ malignancies. All catheters were placed in an outpatient setting on the day of apheresis and remained in site if subsequent collections became necessary. A total of 101 procedures were performed. Thirty-five patients (56%) reached target levels after 1 collection. Twenty-four patients (38%) had 2 consecutive day collections while 4 patients (6%) required more than 2 collections. In this latter group, 2 patients did not have consecutive day collections. One had 2 consecutive day collections followed by a third collection 48 hours later. In the other, leukapheresis was performed for 2 consecutive days and then resumed 3 days later with 2 subsequent collections. The longest duration the catheter remained in site was 6 days. Catheter care was provided by the apheresis staff. All patients who had more than 1 collection were given instructions on how to care for their catheters at home. Only 1 patient had oozing at the catheter site during the collection. Thrombosis, mechanical, and infectious complications were not encountered. The short-term use of femoral venous catheters appears safe and effective for the collection of PBPCs.

KW - Catheter associated complications

KW - PBPC collection

KW - Vascular access

UR - http://www.scopus.com/inward/record.url?scp=0031766840&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031766840&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1098-1101(1998)13:3<99::AID-JCA1>3.0.CO;2-#

DO - 10.1002/(SICI)1098-1101(1998)13:3<99::AID-JCA1>3.0.CO;2-#

M3 - Article

C2 - 9828018

AN - SCOPUS:0031766840

VL - 13

SP - 99

EP - 102

JO - Journal of Clinical Apheresis

JF - Journal of Clinical Apheresis

SN - 0733-2459

IS - 3

ER -